Press "Enter" to skip to content

New patent for Exela Pharma drug ELCYS

0
Copyright © DrugPatentWatch. Originally published at New patent for Exela Pharma drug ELCYS

Annual Drug Patent Expirations for ELCYS
Annual Drug Patent Expirations for ELCYS

Elcys is a drug marketed by Exela Pharma and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.

Drug patent litigation for ELCYS.

The generic ingredient in ELCYS is cysteine hydrochloride. One supplier is listed for this compound. Additional details are available on the cysteine hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Exela Pharma drug ELCYS
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    DrugPatentWatch - Make Better Decisions